Quantum BioPharma announces that Health Canada has granted a Product License for its natural health product, Qlarity. Quantum licensed a similar product, as a dietary supplement, for sale in the United States under the brand name unbuzzd. This Product License from Health Canada permits Quantum to sell Qlarity in Canada. “This is a milestone in Quantum BioPharma’s mission to bring innovative products to the market”, said Zeeshan Saeed, CEO of Quantum BioPharma. “We can now sell Qlarity to the Canadian market, leveraging its significant potential to improve consumer well-being.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma’s Licensee Unbuzzd Wellness to Host Investor Webinar on Innovative Hangover Solution
- Quantum BioPharma Receives BUY Rating from Kingswood Capital Partners
- Quantum BioPharma Announces Key Corporate Updates
- Quantum Group announces corporate updates
- Quantum BioPharma Seeks Shareholder Approval for Private Placement